ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastrointestinal OTC Drugs Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-2F7641
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gastrointestinal OTC Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Gastrointestinal OTC Drugs Market Research Report 2025

Code: QYRE-Auto-2F7641
Report
August 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Pfizer Inc
Johnson & Johnson
Bayer
Procter Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle S A
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma

Gastrointestinal OTC Drugs Market Size

The global market for Gastrointestinal OTC Drugs was valued at US$ 6488 million in the year 2024 and is projected to reach a revised size of US$ 9328 million by 2031, growing at a CAGR of 5.4% during the forecast period.

Gastrointestinal OTC Drugs Market

Gastrointestinal OTC Drugs Market

Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country.
North American market for Gastrointestinal OTC Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Gastrointestinal OTC Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Gastrointestinal OTC Drugs include GlaxoSmithKline, Pfizer, Johnson & Johnson, Bayer, Procter & Gamble, Perrigo, Abbott, Sanofi, Teva Pharmaceutical, Nestle, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastrointestinal OTC Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal OTC Drugs.
The Gastrointestinal OTC Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastrointestinal OTC Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal OTC Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gastrointestinal OTC Drugs Market Report

Report Metric Details
Report Name Gastrointestinal OTC Drugs Market
Accounted market size in year US$ 6488 million
Forecasted market size in 2031 US$ 9328 million
CAGR 5.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Laxatives
  • Anti-Flatulents
  • H2-Antaginists
  • Anti-Diarrheals
  • PPIs
  • Anti-Emetics
  • Other
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Pfizer, Johnson & Johnson, Bayer, Procter & Gamble, Perrigo, Abbott, Sanofi, Teva Pharmaceutical, Nestle, Boehringer Ingelheim, Reckitt Benckiser, Purdue Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gastrointestinal OTC Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gastrointestinal OTC Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Gastrointestinal OTC Drugs Market growing?

Ans: The Gastrointestinal OTC Drugs Market witnessing a CAGR of 5.4% during the forecast period 2025-2031.

What is the Gastrointestinal OTC Drugs Market size in 2031?

Ans: The Gastrointestinal OTC Drugs Market size in 2031 will be US$ 9328 million.

Who are the main players in the Gastrointestinal OTC Drugs Market report?

Ans: The main players in the Gastrointestinal OTC Drugs Market are GlaxoSmithKline, Pfizer, Johnson & Johnson, Bayer, Procter & Gamble, Perrigo, Abbott, Sanofi, Teva Pharmaceutical, Nestle, Boehringer Ingelheim, Reckitt Benckiser, Purdue Pharma

What are the Application segmentation covered in the Gastrointestinal OTC Drugs Market report?

Ans: The Applications covered in the Gastrointestinal OTC Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Gastrointestinal OTC Drugs Market report?

Ans: The Types covered in the Gastrointestinal OTC Drugs Market report are Laxatives, Anti-Flatulents, H2-Antaginists, Anti-Diarrheals, PPIs, Anti-Emetics, Other

1 Gastrointestinal OTC Drugs Market Overview
1.1 Product Definition
1.2 Gastrointestinal OTC Drugs by Type
1.2.1 Global Gastrointestinal OTC Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Laxatives
1.2.3 Anti-Flatulents
1.2.4 H2-Antaginists
1.2.5 Anti-Diarrheals
1.2.6 PPIs
1.2.7 Anti-Emetics
1.2.8 Other
1.3 Gastrointestinal OTC Drugs by Application
1.3.1 Global Gastrointestinal OTC Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Gastrointestinal OTC Drugs Market Size Estimates and Forecasts
1.4.1 Global Gastrointestinal OTC Drugs Revenue 2020-2031
1.4.2 Global Gastrointestinal OTC Drugs Sales 2020-2031
1.4.3 Global Gastrointestinal OTC Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gastrointestinal OTC Drugs Market Competition by Manufacturers
2.1 Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gastrointestinal OTC Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gastrointestinal OTC Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gastrointestinal OTC Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gastrointestinal OTC Drugs, Product Type & Application
2.7 Global Key Manufacturers of Gastrointestinal OTC Drugs, Date of Enter into This Industry
2.8 Global Gastrointestinal OTC Drugs Market Competitive Situation and Trends
2.8.1 Global Gastrointestinal OTC Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gastrointestinal OTC Drugs Players Market Share by Revenue
2.8.3 Global Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gastrointestinal OTC Drugs Market Scenario by Region
3.1 Global Gastrointestinal OTC Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gastrointestinal OTC Drugs Sales by Region: 2020-2031
3.2.1 Global Gastrointestinal OTC Drugs Sales by Region: 2020-2025
3.2.2 Global Gastrointestinal OTC Drugs Sales by Region: 2026-2031
3.3 Global Gastrointestinal OTC Drugs Revenue by Region: 2020-2031
3.3.1 Global Gastrointestinal OTC Drugs Revenue by Region: 2020-2025
3.3.2 Global Gastrointestinal OTC Drugs Revenue by Region: 2026-2031
3.4 North America Gastrointestinal OTC Drugs Market Facts & Figures by Country
3.4.1 North America Gastrointestinal OTC Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gastrointestinal OTC Drugs Sales by Country (2020-2031)
3.4.3 North America Gastrointestinal OTC Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gastrointestinal OTC Drugs Market Facts & Figures by Country
3.5.1 Europe Gastrointestinal OTC Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gastrointestinal OTC Drugs Sales by Country (2020-2031)
3.5.3 Europe Gastrointestinal OTC Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gastrointestinal OTC Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Gastrointestinal OTC Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Gastrointestinal OTC Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Gastrointestinal OTC Drugs Market Facts & Figures by Country
3.7.1 Latin America Gastrointestinal OTC Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gastrointestinal OTC Drugs Sales by Country (2020-2031)
3.7.3 Latin America Gastrointestinal OTC Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gastrointestinal OTC Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gastrointestinal OTC Drugs Sales by Type (2020-2031)
4.1.1 Global Gastrointestinal OTC Drugs Sales by Type (2020-2025)
4.1.2 Global Gastrointestinal OTC Drugs Sales by Type (2026-2031)
4.1.3 Global Gastrointestinal OTC Drugs Sales Market Share by Type (2020-2031)
4.2 Global Gastrointestinal OTC Drugs Revenue by Type (2020-2031)
4.2.1 Global Gastrointestinal OTC Drugs Revenue by Type (2020-2025)
4.2.2 Global Gastrointestinal OTC Drugs Revenue by Type (2026-2031)
4.2.3 Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Gastrointestinal OTC Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gastrointestinal OTC Drugs Sales by Application (2020-2031)
5.1.1 Global Gastrointestinal OTC Drugs Sales by Application (2020-2025)
5.1.2 Global Gastrointestinal OTC Drugs Sales by Application (2026-2031)
5.1.3 Global Gastrointestinal OTC Drugs Sales Market Share by Application (2020-2031)
5.2 Global Gastrointestinal OTC Drugs Revenue by Application (2020-2031)
5.2.1 Global Gastrointestinal OTC Drugs Revenue by Application (2020-2025)
5.2.2 Global Gastrointestinal OTC Drugs Revenue by Application (2026-2031)
5.2.3 Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Gastrointestinal OTC Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Gastrointestinal OTC Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Company Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer Gastrointestinal OTC Drugs Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Procter & Gamble
6.5.1 Procter & Gamble Company Information
6.5.2 Procter & Gamble Description and Business Overview
6.5.3 Procter & Gamble Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Procter & Gamble Gastrointestinal OTC Drugs Product Portfolio
6.5.5 Procter & Gamble Recent Developments/Updates
6.6 Perrigo
6.6.1 Perrigo Company Information
6.6.2 Perrigo Description and Business Overview
6.6.3 Perrigo Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Perrigo Gastrointestinal OTC Drugs Product Portfolio
6.6.5 Perrigo Recent Developments/Updates
6.7 Abbott
6.7.1 Abbott Company Information
6.7.2 Abbott Description and Business Overview
6.7.3 Abbott Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Abbott Gastrointestinal OTC Drugs Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Company Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sanofi Gastrointestinal OTC Drugs Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Teva Pharmaceutical
6.9.1 Teva Pharmaceutical Company Information
6.9.2 Teva Pharmaceutical Description and Business Overview
6.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Portfolio
6.9.5 Teva Pharmaceutical Recent Developments/Updates
6.10 Nestle
6.10.1 Nestle Company Information
6.10.2 Nestle Description and Business Overview
6.10.3 Nestle Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Nestle Gastrointestinal OTC Drugs Product Portfolio
6.10.5 Nestle Recent Developments/Updates
6.11 Boehringer Ingelheim
6.11.1 Boehringer Ingelheim Company Information
6.11.2 Boehringer Ingelheim Description and Business Overview
6.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Portfolio
6.11.5 Boehringer Ingelheim Recent Developments/Updates
6.12 Reckitt Benckiser
6.12.1 Reckitt Benckiser Company Information
6.12.2 Reckitt Benckiser Description and Business Overview
6.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Reckitt Benckiser Gastrointestinal OTC Drugs Product Portfolio
6.12.5 Reckitt Benckiser Recent Developments/Updates
6.13 Purdue Pharma
6.13.1 Purdue Pharma Company Information
6.13.2 Purdue Pharma Description and Business Overview
6.13.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Purdue Pharma Gastrointestinal OTC Drugs Product Portfolio
6.13.5 Purdue Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gastrointestinal OTC Drugs Industry Chain Analysis
7.2 Gastrointestinal OTC Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gastrointestinal OTC Drugs Production Mode & Process Analysis
7.4 Gastrointestinal OTC Drugs Sales and Marketing
7.4.1 Gastrointestinal OTC Drugs Sales Channels
7.4.2 Gastrointestinal OTC Drugs Distributors
7.5 Gastrointestinal OTC Drugs Customer Analysis
8 Gastrointestinal OTC Drugs Market Dynamics
8.1 Gastrointestinal OTC Drugs Industry Trends
8.2 Gastrointestinal OTC Drugs Market Drivers
8.3 Gastrointestinal OTC Drugs Market Challenges
8.4 Gastrointestinal OTC Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Pfizer Inc
Johnson & Johnson
Bayer
Procter Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle S A
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
List of Tables
 Table 1. Global Gastrointestinal OTC Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gastrointestinal OTC Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gastrointestinal OTC Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gastrointestinal OTC Drugs Sales (K Dose) of Key Manufacturers (2020-2025)
 Table 5. Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gastrointestinal OTC Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gastrointestinal OTC Drugs Average Price (USD/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gastrointestinal OTC Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gastrointestinal OTC Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gastrointestinal OTC Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Gastrointestinal OTC Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gastrointestinal OTC Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal OTC Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gastrointestinal OTC Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gastrointestinal OTC Drugs Sales by Region (2020-2025) & (K Dose)
 Table 18. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Gastrointestinal OTC Drugs Sales by Region (2026-2031) & (K Dose)
 Table 20. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Gastrointestinal OTC Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Gastrointestinal OTC Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Gastrointestinal OTC Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gastrointestinal OTC Drugs Sales by Country (2020-2025) & (K Dose)
 Table 27. North America Gastrointestinal OTC Drugs Sales by Country (2026-2031) & (K Dose)
 Table 28. North America Gastrointestinal OTC Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gastrointestinal OTC Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gastrointestinal OTC Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gastrointestinal OTC Drugs Sales by Country (2020-2025) & (K Dose)
 Table 32. Europe Gastrointestinal OTC Drugs Sales by Country (2026-2031) & (K Dose)
 Table 33. Europe Gastrointestinal OTC Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gastrointestinal OTC Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gastrointestinal OTC Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2020-2025) & (K Dose)
 Table 37. Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2026-2031) & (K Dose)
 Table 38. Asia Pacific Gastrointestinal OTC Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gastrointestinal OTC Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gastrointestinal OTC Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gastrointestinal OTC Drugs Sales by Country (2020-2025) & (K Dose)
 Table 42. Latin America Gastrointestinal OTC Drugs Sales by Country (2026-2031) & (K Dose)
 Table 43. Latin America Gastrointestinal OTC Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gastrointestinal OTC Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2020-2025) & (K Dose)
 Table 47. Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2026-2031) & (K Dose)
 Table 48. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gastrointestinal OTC Drugs Sales (K Dose) by Type (2020-2025)
 Table 51. Global Gastrointestinal OTC Drugs Sales (K Dose) by Type (2026-2031)
 Table 52. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Gastrointestinal OTC Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gastrointestinal OTC Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Gastrointestinal OTC Drugs Price (USD/Dose) by Type (2020-2025)
 Table 59. Global Gastrointestinal OTC Drugs Price (USD/Dose) by Type (2026-2031)
 Table 60. Global Gastrointestinal OTC Drugs Sales (K Dose) by Application (2020-2025)
 Table 61. Global Gastrointestinal OTC Drugs Sales (K Dose) by Application (2026-2031)
 Table 62. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Gastrointestinal OTC Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gastrointestinal OTC Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Gastrointestinal OTC Drugs Price (USD/Dose) by Application (2020-2025)
 Table 69. Global Gastrointestinal OTC Drugs Price (USD/Dose) by Application (2026-2031)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline Gastrointestinal OTC Drugs Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 78. Pfizer Gastrointestinal OTC Drugs Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Johnson & Johnson Company Information
 Table 81. Johnson & Johnson Description and Business Overview
 Table 82. Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 83. Johnson & Johnson Gastrointestinal OTC Drugs Product
 Table 84. Johnson & Johnson Recent Developments/Updates
 Table 85. Bayer Company Information
 Table 86. Bayer Description and Business Overview
 Table 87. Bayer Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 88. Bayer Gastrointestinal OTC Drugs Product
 Table 89. Bayer Recent Developments/Updates
 Table 90. Procter & Gamble Company Information
 Table 91. Procter & Gamble Description and Business Overview
 Table 92. Procter & Gamble Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 93. Procter & Gamble Gastrointestinal OTC Drugs Product
 Table 94. Procter & Gamble Recent Developments/Updates
 Table 95. Perrigo Company Information
 Table 96. Perrigo Description and Business Overview
 Table 97. Perrigo Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 98. Perrigo Gastrointestinal OTC Drugs Product
 Table 99. Perrigo Recent Developments/Updates
 Table 100. Abbott Company Information
 Table 101. Abbott Description and Business Overview
 Table 102. Abbott Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 103. Abbott Gastrointestinal OTC Drugs Product
 Table 104. Abbott Recent Developments/Updates
 Table 105. Sanofi Company Information
 Table 106. Sanofi Description and Business Overview
 Table 107. Sanofi Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 108. Sanofi Gastrointestinal OTC Drugs Product
 Table 109. Sanofi Recent Developments/Updates
 Table 110. Teva Pharmaceutical Company Information
 Table 111. Teva Pharmaceutical Description and Business Overview
 Table 112. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 113. Teva Pharmaceutical Gastrointestinal OTC Drugs Product
 Table 114. Teva Pharmaceutical Recent Developments/Updates
 Table 115. Nestle Company Information
 Table 116. Nestle Description and Business Overview
 Table 117. Nestle Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 118. Nestle Gastrointestinal OTC Drugs Product
 Table 119. Nestle Recent Developments/Updates
 Table 120. Boehringer Ingelheim Company Information
 Table 121. Boehringer Ingelheim Description and Business Overview
 Table 122. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 123. Boehringer Ingelheim Gastrointestinal OTC Drugs Product
 Table 124. Boehringer Ingelheim Recent Developments/Updates
 Table 125. Reckitt Benckiser Company Information
 Table 126. Reckitt Benckiser Description and Business Overview
 Table 127. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 128. Reckitt Benckiser Gastrointestinal OTC Drugs Product
 Table 129. Reckitt Benckiser Recent Developments/Updates
 Table 130. Purdue Pharma Company Information
 Table 131. Purdue Pharma Description and Business Overview
 Table 132. Purdue Pharma Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 133. Purdue Pharma Gastrointestinal OTC Drugs Product
 Table 134. Purdue Pharma Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Gastrointestinal OTC Drugs Distributors List
 Table 138. Gastrointestinal OTC Drugs Customers List
 Table 139. Gastrointestinal OTC Drugs Market Trends
 Table 140. Gastrointestinal OTC Drugs Market Drivers
 Table 141. Gastrointestinal OTC Drugs Market Challenges
 Table 142. Gastrointestinal OTC Drugs Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gastrointestinal OTC Drugs
 Figure 2. Global Gastrointestinal OTC Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gastrointestinal OTC Drugs Market Share by Type: 2024 & 2031
 Figure 4. Laxatives Product Picture
 Figure 5. Anti-Flatulents Product Picture
 Figure 6. H2-Antaginists Product Picture
 Figure 7. Anti-Diarrheals Product Picture
 Figure 8. PPIs Product Picture
 Figure 9. Anti-Emetics Product Picture
 Figure 10. Other Product Picture
 Figure 11. Global Gastrointestinal OTC Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 12. Global Gastrointestinal OTC Drugs Market Share by Application: 2024 & 2031
 Figure 13. Hospital Pharmacies
 Figure 14. Retail Pharmacies
 Figure 15. Online Pharmacies
 Figure 16. Global Gastrointestinal OTC Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Gastrointestinal OTC Drugs Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Gastrointestinal OTC Drugs Sales (2020-2031) & (K Dose)
 Figure 19. Global Gastrointestinal OTC Drugs Average Price (USD/Dose) & (2020-2031)
 Figure 20. Gastrointestinal OTC Drugs Report Years Considered
 Figure 21. Gastrointestinal OTC Drugs Sales Share by Manufacturers in 2024
 Figure 22. Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Gastrointestinal OTC Drugs Players: Market Share by Revenue in Gastrointestinal OTC Drugs in 2024
 Figure 24. Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Gastrointestinal OTC Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Gastrointestinal OTC Drugs Sales Market Share by Country (2020-2031)
 Figure 27. North America Gastrointestinal OTC Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Gastrointestinal OTC Drugs Sales Market Share by Country (2020-2031)
 Figure 31. Europe Gastrointestinal OTC Drugs Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Region (2020-2031)
 Figure 39. China Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Gastrointestinal OTC Drugs Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Gastrointestinal OTC Drugs Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. UAE Gastrointestinal OTC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Gastrointestinal OTC Drugs by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Gastrointestinal OTC Drugs by Type (2020-2031)
 Figure 61. Global Gastrointestinal OTC Drugs Price (USD/Dose) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Gastrointestinal OTC Drugs by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Gastrointestinal OTC Drugs by Application (2020-2031)
 Figure 64. Global Gastrointestinal OTC Drugs Price (USD/Dose) by Application (2020-2031)
 Figure 65. Gastrointestinal OTC Drugs Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global OTC Gastrointestinal Products Market Research Report 2024
Global OTC Digestives and Intestinal Remedies Market Research Report 2024
Global Prescription Gastrointestinal Drugs Market Research Report 2024
Global Digestive Drugs Market Insights Forecast to 2030
Global Gastrointestinal Therapeutics Market Research Report 2024
Global Gastrointestinal Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Gastrointestinal Drugs Market Research Report 2025
Global Digestive Remedies Market Research Report 2024
Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastrointestinal Motility Drugs Market Research Report 2024
Gastrointestinal Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide Based Gastrointestinal Disorders Therapeutics Market Research Report 2024
Global OTC Gastritis Drugs Market Research Report 2024
Global Gastrointestinal Rare Diseases Treatment Market Research Report 2025
Global Pediatric Gastrointestinal Drugs Market Research Report 2025
Global Gastroparesis Treatment Products Market Insights Forecast to 2030
Global Gastrointestinal Stents Market Research Report 2024
Gastrointestinal Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Idiopathic Gastroparesis Drugs Market Insights Forecast to 2030
Gastro Esophageal Reflux Disease Drug and Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions